Zydus gets emergency approval for the antiviral drug, may reduce oxygen demand among COVID-19 patients: Details
Zydus has claimed that 91.15 per cent of patients treated with PegIFN were RT-PCR negative by the seventh day
23 April, 2021
Zydus has claimed that 91.15 per cent of patients treated with PegIFN were RT-PCR negative by the seventh day
18 companies given DGCI licence for coronavirus test. After assessment, laboratory technicians will be given licenses.